Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
16.90
+0.49 (2.99%)
At close: Dec 11, 2025, 4:00 PM EST
17.98
+1.10 (6.52%)
Pre-market: Dec 12, 2025, 6:11 AM EST
Eton Pharmaceuticals Market Cap
Eton Pharmaceuticals has a market cap or net worth of $453.22 million as of December 12, 2025. Its market cap has increased by 45.82% in one year.
Market Cap
453.22M
Enterprise Value
446.44M
1-Year Change
45.82%
Ranking
Category
Stock Price
$16.90
Market Cap Chart
Since November 13, 2018, Eton Pharmaceuticals's market cap has increased from $105.74M to $453.22M, an increase of 328.62%. That is a compound annual growth rate of 22.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 452.68M | 27.60% |
| Dec 31, 2024 | 354.78M | 215.68% |
| Dec 29, 2023 | 112.38M | 57.54% |
| Dec 30, 2022 | 71.34M | -32.42% |
| Dec 31, 2021 | 105.56M | -46.38% |
| Dec 31, 2020 | 196.86M | 53.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |